The US Food and Drug Administration is considering removing hangover as an indication from its OTC drug monograph, but the potential change isn’t meant as an opportunity for products marketed as dietary supplements to be recognized as overindulgence remedies.
The agency’s Center for Food Safety Applied Nutrition, apparently beginning an attempt to clear the US marketplace of non-drug products subject to FDA oversight that are promoted or labeled for treating hangovers, has warned seven firms “for illegally selling unapproved products labeled as dietary
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?